VISUtein™ : Featured Product of the Month—Let’s Face it…Worsening Eyesight is ScaryGood eyesight contributes greatly to your wellbeing and quality of life. If you don't take care of your eyes by giving them proper nourishment your eyes can be subject to many degenerative conditions. Without proper care you could even lose this precious gift.Most people don’t even consider that our eyes have special nutrition needs. Many of the common ailments that come with age such as cataracts and macular degeneration can be greatly improved with proper care and nutrition.But how do we obtain these nutrients and in the proper amounts?VISUteinTM — See What You Can Do For Your EyesVISUtein provides a comprehensive combination of vitamins, minerals, herbs, and phytonutrients that are important for maintaining healthy eyes.* Carefully researched and formulated with optimum levels of natural ingredients, VISUtein helps protect and maintain one of your most precious possessions--your sight.Ingredients:VISUtein contains:Vitamin A--essential for night vision*Beta Carotene--significant source of antioxidants to fight against free radical damage*Lutein--protects the lens of the eye against photo-oxidation from sunlight*Zinc--the most abundant trace element in the eye*Bilberry--rich source of anthocyanidins, powerful antioxidant phytonutrients*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.Study:The ingredients in Visutein have proven to improve visual parameters in Age-related Macula Degeneration. Visutein outperforms the leading brand of eye supplement on the market.Unicity International’s leading vision product, VISUtein™, has been studied in a double-blind, controlled study, involving patients with age-related macula degeneration, or AMD. The study was performed by Dr. David Newsome, director of the Louisiana Retinal Institute. AMD leads the causes of untreatable visual loss and legal blindness among persons 65 years old or older in the and other countries.Archives of Ophthalmology in 2004 estimated that 1.75 million residents now have significant symptoms associated with age-related macular degeneration, with that number expected to grow to almost 3 million by 2020.In the current study, Dr. Newsome tested VISUtein in a group of 35 subjects with established AMD. Eighteen of the subjects received VISUtein for a period of 6 months. The remaining 17 subjects used a competitive product called OcuVite, which is based entirely on the AREDS formulation. All subjects had follow up visits at three and six months. Parameters tested were visual acuity, contrast sensitivity, and recovery from a flash:The study group receiving the OcuVite showed no functional loss during the six months and a slight improvement in photo recovery times.The VISUtein group showed improvement in all parameters tested over the six months period.There were clear significant differences between the two groups for all parameters, in favor of VISUtein.This study has proven that VISUtein, providing complete nutritional care for AMD patients, may improve visual parameters, and outperforms the leading commercial brand of vision nutritionals.VISUtein Listed in 2007 Physicians’ Desk Reference:VISUtein is one of the Unicity products listed in the2007 Physicians’ Desk Reference(PDR). The PDR is the nation’s most trusted source of FDA-approved prescribing information, and is consulted by healthcare professionals millions of times each week. The 2007 PDR was distributed to almost half a million MDs and chief pharmacists throughout the . Ninety percent of healthcare professionals consider this reference to most important source of reliable information and it helps them in making the right decision on advising their patients on which products they should use. Ninety percent of healthcare professionals consider this reference to most important source of reliable information and it helps them in making the right decision on advising their patients on which products they should use. www.makelifebetter.com reference # 100295801
...read more
